Proactive Investors highlights Custom Health's appointment of two executives to support the company's next phase of growth.
Mike Palackdharry joins as Chief Commercial and Strategy Officer, bringing more than 30 years of experience leading enterprise businesses and high-growth technology companies. He will oversee commercial strategy, enterprise sales, business development and strategic partnerships, supporting broader adoption of Custom Health's connected medication-management model.
Christina Garcia joins as Chief Compliance and Regulatory Officer, bringing more than 15 years of experience in compliance, privacy and governance across healthcare and life sciences. She will lead the company's enterprise compliance, privacy and governance functions, helping strengthen the foundation for responsible growth across North America.
Together, the appointments reinforce Custom Health's commercial and organizational capabilities as it continues building the infrastructure for medication management at home.
Read the full article on Proactive Investors.
